Wintermute is Now Recruiting Patients for the ZosterEase Phase Ib Clinical Trial. Read more .

Wintermute and Ten Carbon Chemistry Receive US Grant Funding

Wintermute Biomedical collaborates with Ten Carbon Chemistry to explore the potential of GS-2 in reusable food packaging with a $260,000 grant from the US Department of Agriculture.

By
Wintermute Biomedical
,
on
April 12, 2023

Wintermute Biomedical, in collaboration with its spin-off company Ten Carbon Chemistry (TCC), has received a $260,000 grant from the US Department of Agriculture to explore the effectiveness of GS-2 in reusable food packaging. The grant is for a period of two years.

This comes from the International Fresh Produce Association's Fresh Field Catalyst program TCC was accepted into in 2022. This program supports startups in the produce and floral industry to create innovative solutions to major sector challenges. 

The safety profile of GS-2 means it is appropriate to use around food and is a great substitute for the currently used chemicals. 

"If GS-2 can demonstrate antimicrobial activity in this project, this gives us the power to go to the big food companies to propose a license deal," says Dr. Tony Peacock, Chairman of Wintermute Biomedical.

Grant activities have already begun early in 2023, and TCC is excited to explore the potential of GS-2 in the food industry. TCC is also exploring the activity of GS-2 and other antimicrobial formulations in industry and agriculture. You can find out more about TCC here.